Etizolam (marketed under many brand names) is a thienodiazepine derivative which is a benzodiazepine analog. … The etizolam molecule differs from a …Trade names: Etizest, Etilaam, Etizex, Depas, …Dependence liability: ModerateMetabolism: HepaticRoutes of administration: Oral, sublingua
Etizolam is used in the treatment of short term anxiety and insomnia. Etizolam is a benzodiazepine. It works by increasing the action of a chemical messenger (GABA) which suppresses the abnormal and excessive activity of the nerve cells in the brain. contact us to order for etizolam powder and tablets
Is Etizolam a muscle relaxant?
Etizolam has sedative effects and is a muscle relaxant. It interacts with a neurotransmitter in the central nervous system that controls the firing of neurons. As a result, it is a depressant drug that slows everything down. buy etizolam best price here
Etizolam is a thienodiazepine which is chemically related to benzodiazepine (BDZ) drug class; it differs from BDZs in having a benzene ring …Drug classes: Thienodiazepine. buy etizolam best prices online order now
Etizolam (marketed under many brand names) is a thienodiazepine derivative which is a benzodiazepine analog. The etizolam molecule differs from a benzodiazepine in that the benzene ring has been replaced by a thiophene ring and triazole ring has been fused, making the drug a thienotriazolodiazepine.
Although a thienodiazepine, etizolam is clinically regarded as a benzodiazepine because of its mode of action via the benzodiazepine receptor and directly targeting GABAA receptors.
It possesses anxiolytic, amnesic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. Etizolam is an anxiolytic found to have lower tolerance and dependence liability than benzodiazepines
It was patented in 1972 and approved for medical use in 1983
Tolerance, dependence and withdrawal
Abrupt or rapid discontinuation from etizolam, as with benzodiazepines, may result in the appearance of the benzodiazepine withdrawal syndrome, including rebound insomnia.
Neuroleptic malignant syndrome, a rare event in benzodiazepine withdrawal, has been documented in a case of abrupt withdrawal from etizolam. This is particularly relevant given etizolam’s short half life relative to benzodiazepines such as diazepam resulting in a more rapid drug level decrease in blood plasma levels.
In a study that compared the effectiveness of etizolam, alprazolam, and bromazepam for the treatment of generalized anxiety disorder, all three drugs retained their effectiveness over 2 weeks, but etizolam became more effective from 2 weeks to 4 weeks. Administering .5 mg etizolam twice daily did not induce cognitive deficits over 3 weeks when compared to placebo.